Diabetes mellitus (DM)-associated ED is predominantly due to neurovascular dysfunction mediated by nitric oxide (NO) suppression. Panax notoginseng saponins (PNS) are widely used for treating cardiovascular disease in China. The aim of this study was to evaluate the effects of PNS on penile erection and corpus cavernosum tissues in rats with diabetes-associated ED. Four weeks after PNS treatment, erectile function was assessed by intracavernous pressure (ICP) and mean arterial pressure (MAP) measurements. The level of NO, cyclic guanosine monophosphate (cGMP) and advanced glycation end products (AGEs) in cavernous tissue were assessed. Immunohistochemical staining and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) were performed for detecting endothelial NO synthase (eNOS) and apoptosis, respectively. The results show that ICP/MAP ratio was significantly increased in high-dose (150 mg kg À 1 per day) PNS-treated group compared with the diabetic ED untreated group (DM group). Compared with the untreated group, the expression of eNOS and the levels of NO and cGMP were increased in the PNS-treated groups. Moreover, apoptosis was markedly decreased in the group that received 150 mg kg À 1 per day of PNS. These results suggest that PNS may be used for improving the ED in diabetic rats via the NO/cGMP pathway and restores the function of endothelium in corpus cavernosum.
INTRODUCTION
ED is recognized as a serious and common chronic complication of diabetes mellitus (DM). 1 ED in diabetes patients usually starts 10-15 years earlier than in the general population. Recent studies on the molecular pathophysiologic mechanisms of diabetesinduced ED have suggested that this disease is predominantly due to neurovascular dysfunction. Normal erectile function primarily depends on vasodilatation, which is mainly regulated by both nerve and endothelium-derived nitric oxide (NO). 2 Under a normal situation, the endothelial NO synthase (eNOS) produces a physiological level of NO in endothelial cells. From a recent review, it is clear that NO production is markedly decreased, which is correlated with reduced eNOS expression in the penis of diabetic rats, following chemical diabetogenesis. 3 Previous studies have shown that high blood glucose levels can increase accumulation of advanced glycation end products (AGEs) that are responsible for low neuronal and endothelial-derived NOmediated relaxation of corpus cavernosum. 4 When dysfunction occurs in penis endothelial cells, erectile function may be disrupted. Thus, diabetes has the potential to have an impact on all the components of the erectile response.
Multiple approaches have been used to treat diabetes ED. These includes diabetes control, psychosexual counseling, PDE5 inhibitors and antihypertensive medications. 5 The PDE5 inhibitors, such as sildenafil, vardenafil and tadalafil, are efficacious oral medicine for ED therapy. The efficacy of the PDE5 inhibitors is mainly due to counteraction of the degradation of cGMP, which is generated via NO/cGMP pathway. 6 Although PDE5 inhibitor has shown good results in treating ED in nondiabetic ones, its efficacy is significantly lower in diabetic ED patients. 7, 8 Panax notoginseng is one of the most widely used traditional Chinese herbal medicines for the treatment of coronary heart disease, atherosclerosis, cardiac angina and apoplexy in China. Panax notoginseng saponins (PNS) are the main active ingredient of Panax notosinseng, which is reported to be responsible for the therapeutic action of this medicine. Ginsenosides Rg1, Rb1 and Rd, and notoginsenoside R1 are considered to be the major components of PNS. 9 Numerous studies have demonstrated that PNS has extensive effects on the cardiovascular system, including increasing blood flow through the coronary arteries, promoting angiogenesis, 10, 11 inhibiting vessel restenosis after vascular intimal injury, 12 protecting on lipopolysaccharide-induced microcirculatory disturbance, 13 and maintaining the normal expansion and contraction of vascular smooth muscle. 14, 15 In addition, PNS improves the sensitivity of insulin and leptin, which contributes to its anti-hyperglycemic and anti-obese activities. 16 Meanwhile, PNS could enhance the mRNA expression of the most important vascular endothelial growth factor. 11 Recent studies have shown that intracavernous injection of vascular endothelial growth factor improves ED through restoration of the insulin-like growth factor system and sex hormone receptor genes at the mRNA and protein levels, and inhibition of apoptosis in corpora cavernosa in diabetic rats. 17, 18 Those effects suggest that the restoration of the endothelial function could be a valuable approach for treating ED in DM. In this study, we investigated the hypothesis that by improving the erectile function in DM via the NO/cGMP pathway, PNS restores the function of endothelium in corpus cavernosum. The results suggest that PNS improves the ED in diabetic rats via the NO/cGMP pathway and restores the function of endothelium in corpus cavernosum.
MATERIALS AND METHODS

Experimental animals
Sprague-Dawley rats (male, 180-220 g of body weight) were purchased from the Laboratory Animal Center of Chongqing Medical University, and were housed in a specific pathogen-free environment and given ad libitum access to food and water. All procedures were carried out in accordance with guidelines of the Chinese animal use, and were approved by the ethics committee of Chongqing Medical University.
After fasting for 16 h with free access of water, diabetes was induced by intraperitoneal injection of streptozotocin (STZ; Sigma Chemical, St Louis, MO, USA, 60 mg kg À 1 ) in sterile citrate buffer. The normal rats of the control group (n ¼ 6) were injected with an equivalent volume of citrate buffer. The rats were examined for blood glucose via tail vein using an Ultra Vue glucose monitor (Johnson & Johnson, Shanghai, China) at 1 and 2 weeks after STZ injection. The rats were considered diabetic if their blood glucose levels were above 16.7 mmol l À 1 at the two examining time points. At 12 weeks of diabetes, the rats were placed in a transparent observation cage, and were put in a tranquil laboratory without light for 10 min to allow them to adapt to the new environment. The rats were injected with apomorphine (APO; Sigma Chemical, 100 ml kg À 1 ) subcutaneously to the back of the neck. The frequency of penile erection of each tested animal was observed and recorded by researchers for 30 min. An erection was counted only if the emergence of an engorged glans penis and distal shaft was noted. The rats showing no erection were considered to have ED and used for further experiments.
Treatment of rats with PNS
The diabetes-associated ED rats were randomly divided into four groups (n ¼ 6 in each group): PNS50, PNS100 and PNS150 groups, which received 50, 100 and 150 mg kg À 1 per day of PNS, respectively, and the DM group that consists of diabetic ED rats receiving normal saline. PNS (Weikeqi Biological Technology, Sichuan, China) was injected intraperitoneally daily for 4 weeks. Control group was injected intraperitoneally once daily with normal saline of the same volume. Body weight and glucose levels were monitored at 2 and 4 weeks in all animals post treatment.
Determination of erectile function
Four weeks after PNS injection, the rats were anesthetized with an intraperitoneal injection of 3.5 ml of 10% chloral hydrate. 19 Using a low abdominal midline incision, the right major pelvic ganglion was exposed, and the ipsilateral cavernosal nerve was identified. The skin overlying the penis was sundered and both penile crura were exposed by removing part of the overlying ischiocavernous muscle. To monitor intracavernosal pressure (ICP), the right crus was cannulated with a 25-G butterfly needle with 250 U ml À 1 heparin-saline solution and connected to a pressure transducer, and the right cavernosal nerve was stimulated with a bipolar silver electrode. To record the mean arterial pressure (MAP), a PE-50 tube with 250 U ml À 1 heparinized saline fitted to a pressure transducer was inserted into the left carotid artery via a midline neck incision. Stimulus parameters were 10 V, 20 Hz and 0.2 ms (wave amplitude). The stimulation at this frequency lasted for 50 s and the curve was repeated after an interval of 5 min. ICP and MAP were converted from analog to digital signals and transmitted to a data-acquisition program, and analyzed with BL-420 F Data Acquisition & Analysis System (Chengdu Tme Technology, Chengdu, China). Maximum ICP and ICP/MAP ratio were recorded.
NO production assay
The corpus cavernosum was collected from all rats and homogenized in cold phosphate-buffered solution at 2-8 1C to prepare a 10% (w/v) homogenates. Each homogenized penis sample was centrifuged at 1500 Â g for 15 min at 4 1C and the supernatants were recovered. The supernatant (50 ml) of each homogenized penis sample was used to detect NO by using the Nitric Oxide Assay kit (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). The protein content per mg tissue was determined with a coomassie brilliant blue protein assay kit, according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, China). 20, 21 Absorbance was measured at 550 nm in a microplate reader (Thermo Fisher Scientific, Waltham, MA, USA) and the NO level was detected according to the standard graph of sodium nitrite (in the range 1-10 mmole ml À 1 ).
cGMP and AGEs analysis
The level of tissue-active AGEs was measured by ELISA using the Rat AGEs ELISA Kit, following the manufacturer's instructions (BIOTANG, Walthem, MA, USA). cGMP was performed by ELISA using the cGMP Parameter Assay Kit in accordance with the protocol specified by the manufacturer (R&D Systems, Minneapolis, MN, USA).
Immunohistochemistry
The tissue samples were fixed, paraffin-embedded and then sectioned at 5-m thickness. After dewaxing and rehydrating, the tissue sections were washed with phosphate-buffered saline and treated with 3% hydrogen peroxide (H 2 O 2 ) for 15 min at 37 1C to inhibit endogenous peroxidase activity. Antigen retrieval was performed by placing the sections in citrate buffer and heated for 30 min in a microwave oven. The sections were blocked in 4% goat serum for 30 min at 37 1C, followed by incubation at 4 1C overnight with primary anti-eNOS antibody (BD Biosciences, San Jose, CA, USA; 1:100 dilution). The sections were then incubated with biotinconjugated secondary antibody (Zhongshan Golden Bridge Biotechnology, Beijing, China) for 30 min at 37 1C and subsequently avidin-biotin horseradish peroxidase complex for 30 min at 37 1C, and followed by treatment with DAB chromogen for reaction visualization. The sections were counterstained with diluted hematoxylin and mounted with neutral gum. In the negative control, the primary antibody was replaced by phosphate-buffered solution. For image analysis, five randomly selected fields per section were photographed and recorded. Quantitative image analysis of the Â 400 magnification images was performed by computerized densitometry using the Image-Pro Plus image analysis software (Media Cybernetics, Bethesda, MD, USA).
TUNEL assay for apoptosis
To quantify apoptosis in the penile cavernous tissue, TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay was performed on the paraffin sections using the TUNEL apoptosis detection kit (KeyGEN biotech, Nanjing, China). Five areas were randomly selected for each tissue section by visual observation at a magnification of Â 400 and then photographed for further digital image analysis. The number of brownstained apoptotic cells was counted together with the total number of cells in these selected fields, with the aid of the software-based cell counting program Image-Pro Plus. The percentage of apoptotic cells in the five fields from each section was calculated.
Statistical analysis
All results were analyzed by using the SSPS 15.0 software (SPSS, Chicago, IL, USA). Statistical analyses of all data were performed using a one-way analysis of variance followed by Tukey's test to determine significant differences. Data were expressed as mean±s.d. For all experiments, Po0.05 was considered statistically significant.
RESULTS
Body weights and blood glucose level
The body weight and blood glucose level of the rats at the beginning of PNS treatment and during the course of treatment are shown in Table 1 . At 4 weeks of the experiments, body weight increase in all diabetic ED groups was significantly lower than that of the control group at both the 2 and 4 week points (*Po0.05). The PNS100 and PNS150 groups had significantly higher weight gain than the DM group at week 4 ( # Po0.05). Four weeks after PNS treatment, the blood glucose levels in all the PNS-treated groups were significantly lower than in that of the DM group ( # Po0.05).
In vivo erectile function
The results of ICP increase and ICP/MAP ratio monitored in the experimental animals are shown in Figure 1 . After stimulating the Panax notoginseng saponins in treating diabetic ED F Lin and X Gou PNS resulted in significant improvement of erectile function compared with the untreated DM group, which were demonstrated by significant ICP increase and ICP/MAP (*Po0.05, Figure 1b ).
NO levels
The results of NO concentrations in corpora cavernosa tissues are shown in Figure 2 . Compared with the control group, the DM group had dramatically decreased NO level (*Po0.05). At the same time, the PNS150 group had significantly increased NO level compared with the DM group (*Po0.05). The PNS100 group also showed an increased level of NO compared with that of the DM group (*Po0.05).
Effect of PNS on AGEs and cGMP
The cGMP and AGEs levels in corpora cavernosa tissues were measured by ELISA, and the results were shown in Figure 3 . Compared with the control group, the cGMP concentration had dramatically decreased in the DM group (*Po0.05). Simultaneously, The cGMP concentration was markedly increased in the PNS100 and PNS150 groups as compared with that of the DM group (*Po0.05, Figure 3a) . The AGEs levels in all the PNS-treated groups were significantly decreased compared with that of the DM group (*Po0.05, Figure 3b ). However, there was no statistical difference among the three PNS-treated groups.
Changes of eNOS expression in corpora cavernosa eNOS was detected by immunohistochemistry on the corpora cavernosa of all experimental groups and the results were shown in Figure 4 . eNOS was intensely positive in the corpus cavernosum tissues from the control group, moderate in the PNS150 group and weakly positive in the PNS50 and PNS100 groups, and in the DM group (Figure 4a ). The expression of eNOS was much higher in the PNS150 group compared with the DM group (*Po0.05, Figure 4b ).
Cell apoptosis in corpora cavernosa Compared with the control group, the apoptosis index had significantly increased in the DM group (*Po0.05, Figure 4c ). Apoptosis index was increased in the corpora cavernosa from the diabetic ED rats treated with all the three doses of PNS compared with that of rats treated with vehicle (*Po0.05, Figure 4c ).
DISCUSSION
A growing body of evidence suggests that endothelial dysfunction is highly associated to diabetes-associated ED. 22, 23 Although the precise mechanisms leading to endothelial dysfunction in the diabetic vasculature, including in the penis, are not fully understood, hyperglycemia-induced endothelial dysfunction is clearly recognized as the primary cause in the pathogenesis of the vascular complications of DM. 24 Various techniques, such as visual assessment, scoring of various erectile parameters and video recording of the extent of the erectile response, are used to record penile erections in animal models in vivo. 25, 26 As a direct index, although visible penile erection has more important value to assess the context of the observed pressure change, the difficulty of accurate observation, especially for inexperienced trainee, limited the application of this method. Thus, we chose the recording of ICP and ICP/MAP ratio as the primary indices of erectile function in our research. Measuring ICP and ICP/MAP ratio provides an objective and accurate quantitative index to evaluate penile erections, and has been extensively used in penile erection research in rats. 27, 28 In addition, these two parameters are well correlated with the visible penile erection that reflects erectile function. 29, 30 In the current study, we found that the ICP/MAP ratio and the ICP increase, as two parameters of erectile function, were significantly increased in the PNS150 group. Therefore, our results suggest that PNS likely restores the erectile response in the diabetes-associated ED rats. It has been shown that diabetes exacerbates the functional deficiency in the NO/cGMP pathway in diabetes-associated ED patients. 31 Additionally, eNOS-and nNOS-mediated cavernosal smooth muscle relaxation is impaired in diabetic animals. 32 Evidence from both basic and clinical researches show that the functional deficiency of the NO/cGMP pathway markedly participates in the development of diabetes-associated ED. In the present study, the expression of eNOS, and the levels of NO and cGMP in corpora cavernosa tissues were markedly increased after administration of PNS to the diabetic ED rats. The positive effects are likely due to the function of ginsenoside Rg1, which is one of the major active components in PNS. Rg1 was reported to induce eNOS phosphorylation and NO production via the nontranscriptional PI3K/Akt pathway. 33 Recent studies show that Rg1 is able to downregulate miRNA-214 expression in human umbilical vein endothelial cells, leading to increased eNOS expression, 34 enhanced NO production and the expression of eNOS mRNA in tumor necrosis factor-alpha-stimulated human umbilical vein endothelial cells. 35 In view of the proposed mechanisms of diabetes-induced ED, AGEs may have an important role through participating in the development of vascular complications in diabetes. Increased glucose level promotes the formation of AGEs, which accumulate in the corpus cavernosal tissue, particularly in the endothelial and smooth muscle cells, and contribute to the pathogenesis of diabetes-associated ED. 4, 36 AGEs form covalent bonds with vascular collagen, which leads to vascular thickening, elasticity decrease, endothelial dysfunction and atherosclerosis development. 37 It is suggested that AGEs contribute to diabetic ED by generating free radicals or reactive oxygen species that induce oxidative cell damage, NO quenching, cGMP decrease and cavernosal smooth muscle relaxation impairment. 4 Our data show that PNS reduced blood glucose level and corpus cavernosum AGEs. Although the blood glucose levels of experimental animals did not return to the normal level in the PNS-treated rats, a significant decrease was clearly detected. Thus, reduction of glucose may have a role in improving diabetesassociated ED. Previous studies have indicated that PNS possesses anti-hyperglycemic activity and a therapeutic potential for hyperglycemia in type 2 diabetes through enhancing insulinstimulated glucose uptake and glycogen synthesis 38 or improving insulin-and leptin sensitivity; ginsenoside Rb1 is reported to be responsible for the anti-hyperglycemic effect. 16 However, in this study, we used a type 1 diabetes model that is impaired in insulin production but not in insulin sensitivity. How PNS worked in this model in suppressing glucose level is currently unknown. It is likely that other mechanisms by some PNS component(s) contributes to the glucose-regulating effect, which certainly needs further investigation. Nevertheless, effectively controling AGEs and glucouse may prevent progress of vascular endothelium damage.
Previous studies have shown that the ratio of apoptotic cells in the erectile tissues in diabetic rats was significantly increased compared with that in normal rats. 39 The expression of apoptotic factors, such as Bak and Bax, are increased in the diabetic rat penile crura. 40 Recent studies show that PNS effectively protects liver grafts from ischemia/reperfusion injury in rats receiving orthotopic liver transplantation, which is achieved by inhibiting the expression of tumor necrosis factor-alpha and caspase-3, and increasing the expression of Bcl-2. 41 PNS has a protective effect on oxidative stress-induced damage and apoptosis in cultured rabbit bone marrow stromal cells, which is associated with scavenging reactive oxygen species and regulating the Bcl-2/Bax pathway. 42 In addition, PNS promotes endothelial regeneration by regulating the expression of vascular endothelial growth factor. These evidence suggest that PNS possesses an anti-apoptotic activity, although the specific mechanisms in diabetic ED need further investigation.
In conclusion, the present study provides evidence that PNS increases the expression of eNOS, controls the accumulation of AGEs and inhibits cell apoptosis, suggesting that PNS could be used for protecting endothelial function in the penile corpus cavernosum. Treatment with PNS is likely beneficial to the restoration of erectile response, which suggests that utilization of PNS to protect endothelial function may represent a new therapeutic avenue in the treatment of patients with diabetesrelated ED. Undoubtedly, the defined mechanism of PNS in improving erectile function requires further study.
